Results 201 to 210 of about 33,525 (245)
Some of the next articles are maybe not open access.
Dermatologic Clinics, 1987
Although a specific etiology remains undetermined, most evidence points to an autoimmune pathogenesis for alopecia areata. Treatments for alopecia areata are likely to remain palliative until its etiology is better understood. Even it prolonged remissions cannot always be achieved with the treatments presently available, preservation of hair regrowth ...
A J, Mitchell, M R, Balle
openaire +2 more sources
Although a specific etiology remains undetermined, most evidence points to an autoimmune pathogenesis for alopecia areata. Treatments for alopecia areata are likely to remain palliative until its etiology is better understood. Even it prolonged remissions cannot always be achieved with the treatments presently available, preservation of hair regrowth ...
A J, Mitchell, M R, Balle
openaire +2 more sources
2008
The pathogenesis of organ specific, cell mediated autoimmune alopecia areata (AA) has substantially progressed in the last decade. These advances are partly based upon advances in immunology and genetics, improved technological methodology in RNA, DNA, proteomics, and computer analyses, as well as the development of the C3H/HeJ mouse model of AA.
King, L E, McElwee, K J, Sundberg, J P
openaire +2 more sources
The pathogenesis of organ specific, cell mediated autoimmune alopecia areata (AA) has substantially progressed in the last decade. These advances are partly based upon advances in immunology and genetics, improved technological methodology in RNA, DNA, proteomics, and computer analyses, as well as the development of the C3H/HeJ mouse model of AA.
King, L E, McElwee, K J, Sundberg, J P
openaire +2 more sources
Microchimerism in alopecia areata
International Journal of Dermatology, 2015AbstractBackgroundAutoimmunity is the main etiopathogenetic factor in alopecia areata. Microchimerism is the existence of allogeneic DNA in a living creature. There are variable studies investigating the role of microchimerism on the etiopathogenesis of autoimmune diseases.
Erdinç, Terzi +6 more
openaire +2 more sources
The genetics of alopecia areata
Clinics in Dermatology, 2001Although the inheritance of alopecia areata (AA) is not definitively known, there is increasing consensus that it is an organ-specific autoimmune disease directed against the hair follicle. The major histocompatibility complex (MHC) on chromosome 6p21 that encodes surface proteins for self-recognition is now recognized as a major contributing factor ...
M, Duvic, A, Nelson, M, de Andrade
openaire +2 more sources
Photochemotherapy and Alopecia Areata
International Journal of Dermatology, 1983ABSTRACT: Four of ten patients with alopecia areata (plaque and totalis types) showed some regrowth of hair after PUVA therapy using a light box with peak emission 365 nm. Because PUVA may have long term side effects, this therapy should be reserved for patients resistant to other treatments.
M A, Amer, A, El Garf
openaire +2 more sources
Journal of the American Academy of Dermatology, 2000
Alopecia areata (AA) is a nonscarring hair loss condition. Among the many factors under investigation in the pathogenesis of AA, the main areas of concentration have been genetic constitution as well as nonspecific immune and organ-specific autoimmune reactions.
S, Madani, J, Shapiro
openaire +2 more sources
Alopecia areata (AA) is a nonscarring hair loss condition. Among the many factors under investigation in the pathogenesis of AA, the main areas of concentration have been genetic constitution as well as nonspecific immune and organ-specific autoimmune reactions.
S, Madani, J, Shapiro
openaire +2 more sources
Dermatologic Clinics
Advances in understanding of AA have led to the first approved therapies for this disease, and in the past two years, there have been three medicines approved for the treatment of severe alopecia areata. There are numerous clinical trials of novel therapeutics underway across the spectrum of AA.
Luiza, Kalil, Brett, King
openaire +2 more sources
Advances in understanding of AA have led to the first approved therapies for this disease, and in the past two years, there have been three medicines approved for the treatment of severe alopecia areata. There are numerous clinical trials of novel therapeutics underway across the spectrum of AA.
Luiza, Kalil, Brett, King
openaire +2 more sources
Archives of Dermatology, 1985
To the Editor.— Claudy and Gagnaire1reported hair regrowth after treatment with systemic psoralens and UV-A (PUVA) in 64% (11 of 17) patients with alopecia areata (AA). Endocrine disorders were not reported, and the racial background (ie, white or nonwhite) of the seven women and 16 men, who were selected for treatment without apparent bias, was not ...
openaire +2 more sources
To the Editor.— Claudy and Gagnaire1reported hair regrowth after treatment with systemic psoralens and UV-A (PUVA) in 64% (11 of 17) patients with alopecia areata (AA). Endocrine disorders were not reported, and the racial background (ie, white or nonwhite) of the seven women and 16 men, who were selected for treatment without apparent bias, was not ...
openaire +2 more sources